Related Articles
Grading of pancreatic neuroendocrine neoplasms using pharmacokinetic parameters derived from dynamic contrast‑enhanced MRI
Contrast-enhanced dynamic and diffusion-weighted magnetic resonance imaging at 3.0 T to assess early-stage nasopharyngeal carcinoma
Pharmacokinetic analysis for the differentiation of pituitary microadenoma subtypes through dynamic contrast‑enhanced magnetic resonance imaging
Application evaluation of DCE‑MRI combined with quantitative analysis of DWI for the diagnosis of prostate cancer
Quantitative analysis of 3-Tesla magnetic resonance imaging in the differential diagnosis of breast lesions